Titre : Infarctus du territoire de l'artère cérébrale postérieure

Infarctus du territoire de l'artère cérébrale postérieure : Questions médicales fréquentes

Termes MeSH sélectionnés :

Attention Deficit Disorder with Hyperactivity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Infarctus du territoire de l'artère cérébrale postérieure : Questions médicales les plus fréquentes", "headline": "Infarctus du territoire de l'artère cérébrale postérieure : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Infarctus du territoire de l'artère cérébrale postérieure : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-02", "dateModified": "2025-02-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Infarctus du territoire de l'artère cérébrale postérieure" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Infarctus cérébral", "url": "https://questionsmedicales.fr/mesh/D002544", "about": { "@type": "MedicalCondition", "name": "Infarctus cérébral", "code": { "@type": "MedicalCode", "code": "D002544", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.717.489.250.200" } } }, "about": { "@type": "MedicalCondition", "name": "Infarctus du territoire de l'artère cérébrale postérieure", "alternateName": "Infarction, Posterior Cerebral Artery", "code": { "@type": "MedicalCode", "code": "D020762", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hideki Endo", "url": "https://questionsmedicales.fr/author/Hideki%20Endo", "affiliation": { "@type": "Organization", "name": "Department of Neurosurgery, Nakamura Memorial Hospital, South 1, West 14, Chuo-Ku, Sapporo, Hokkaido, 060-8570, Japan. endo@med.nmh.or.jp." } }, { "@type": "Person", "name": "Hirohiko Nakamura", "url": "https://questionsmedicales.fr/author/Hirohiko%20Nakamura", "affiliation": { "@type": "Organization", "name": "Department of Neurosurgery, Nakamura Memorial Hospital, South 1, West 14, Chuo-Ku, Sapporo, Hokkaido, 060-8570, Japan." } }, { "@type": "Person", "name": "Mugurel Constantin Rusu", "url": "https://questionsmedicales.fr/author/Mugurel%20Constantin%20Rusu", "affiliation": { "@type": "Organization", "name": "Division of Anatomy, Department 1, Faculty of Dentistry, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania." } }, { "@type": "Person", "name": "Hidetoshi Ono", "url": "https://questionsmedicales.fr/author/Hidetoshi%20Ono", "affiliation": { "@type": "Organization", "name": "Department of Radiology, Nakamura Memorial Hospital, Sapporo, Hokkaido, Japan." } }, { "@type": "Person", "name": "Thomas Benke", "url": "https://questionsmedicales.fr/author/Thomas%20Benke", "affiliation": { "@type": "Organization", "name": "Clinic of Neurology, Medical University Innsbruck, Innsbruck, Austria." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).", "datePublished": "2023-03-27", "url": "https://questionsmedicales.fr/article/36971690", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD009885.pub3" } }, { "@type": "ScholarlyArticle", "name": "Altered somatosensory processing in adult attention deficit hyperactivity disorder.", "datePublished": "2024-08-13", "url": "https://questionsmedicales.fr/article/39138461", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12888-024-06002-9" } }, { "@type": "ScholarlyArticle", "name": "Parental perspectives on attention-deficit/hyperactivity disorder treatments for children.", "datePublished": "2022-06-13", "url": "https://questionsmedicales.fr/article/35695509", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/13591045221108836" } }, { "@type": "ScholarlyArticle", "name": "Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder.", "datePublished": "2022-10-27", "url": "https://questionsmedicales.fr/article/36361835", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms232113054" } }, { "@type": "ScholarlyArticle", "name": "Sensory Processing in Children and Adolescents with Attention Deficit Hyperactivity Disorder.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36239408", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/10870547221129306" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Nécrose", "item": "https://questionsmedicales.fr/mesh/D009336" }, { "@type": "ListItem", "position": 5, "name": "Infarctus", "item": "https://questionsmedicales.fr/mesh/D007238" }, { "@type": "ListItem", "position": 6, "name": "Infarctus encéphalique", "item": "https://questionsmedicales.fr/mesh/D020520" }, { "@type": "ListItem", "position": 7, "name": "Infarctus cérébral", "item": "https://questionsmedicales.fr/mesh/D002544" }, { "@type": "ListItem", "position": 8, "name": "Infarctus du territoire de l'artère cérébrale postérieure", "item": "https://questionsmedicales.fr/mesh/D020762" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Infarctus du territoire de l'artère cérébrale postérieure - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Infarctus du territoire de l'artère cérébrale postérieure", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Infarctus du territoire de l'artère cérébrale postérieure", "description": "Comment diagnostiquer un infarctus cérébral postérieur ?\nQuels tests sont nécessaires après un AVC suspecté ?\nQuels signes cliniques indiquent un infarctus postérieur ?\nQuelle est l'importance de l'ECG dans le diagnostic ?\nPeut-on utiliser des biomarqueurs pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D020762?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Infarctus du territoire de l'artère cérébrale postérieure", "description": "Quels sont les symptômes d'un infarctus cérébral postérieur ?\nComment se manifestent les troubles visuels ?\nY a-t-il des signes de confusion mentale ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?\nQuels sont les signes d'alerte d'un AVC ?", "url": "https://questionsmedicales.fr/mesh/D020762?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Infarctus du territoire de l'artère cérébrale postérieure", "description": "Comment prévenir un infarctus cérébral postérieur ?\nLe tabagisme influence-t-il le risque d'AVC ?\nL'activité physique peut-elle réduire le risque ?\nQuels aliments sont à privilégier pour la prévention ?\nLe contrôle du diabète est-il important ?", "url": "https://questionsmedicales.fr/mesh/D020762?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Infarctus du territoire de l'artère cérébrale postérieure", "description": "Quels traitements sont disponibles pour un infarctus postérieur ?\nQuelle est l'importance de la rééducation ?\nLes médicaments peuvent-ils prévenir d'autres AVC ?\nQuand est-il nécessaire d'intervenir chirurgicalement ?\nQuels sont les effets secondaires des traitements ?", "url": "https://questionsmedicales.fr/mesh/D020762?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Infarctus du territoire de l'artère cérébrale postérieure", "description": "Quelles complications peuvent survenir après un AVC ?\nComment les troubles cognitifs peuvent-ils évoluer ?\nLes AVC peuvent-ils entraîner des problèmes émotionnels ?\nY a-t-il un risque accru de nouveaux AVC ?\nComment gérer les complications à long terme ?", "url": "https://questionsmedicales.fr/mesh/D020762?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Infarctus du territoire de l'artère cérébrale postérieure", "description": "Quels sont les principaux facteurs de risque d'AVC ?\nL'âge influence-t-il le risque d'infarctus cérébral ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il contribuer au risque d'AVC ?\nLes maladies cardiaques sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D020762?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un infarctus cérébral postérieur ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un scanner ou une IRM cérébrale est utilisé pour visualiser les lésions." } }, { "@type": "Question", "name": "Quels tests sont nécessaires après un AVC suspecté ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests neurologiques et des examens d'imagerie sont essentiels." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un infarctus postérieur ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles visuels, des pertes de mémoire et des déséquilibres peuvent survenir." } }, { "@type": "Question", "name": "Quelle est l'importance de l'ECG dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'ECG aide à détecter des arythmies pouvant causer un AVC." } }, { "@type": "Question", "name": "Peut-on utiliser des biomarqueurs pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des biomarqueurs sanguins peuvent aider à évaluer les lésions cérébrales." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un infarctus cérébral postérieur ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles de la vision, des vertiges et des maux de tête." } }, { "@type": "Question", "name": "Comment se manifestent les troubles visuels ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent inclure une vision floue, des hallucinations visuelles ou une perte de vision." } }, { "@type": "Question", "name": "Y a-t-il des signes de confusion mentale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la mémoire et de la compréhension peuvent se produire." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la combinaison des symptômes peuvent différer selon les individus." } }, { "@type": "Question", "name": "Quels sont les signes d'alerte d'un AVC ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des engourdissements, des difficultés à parler ou à marcher sont des signes d'alerte." } }, { "@type": "Question", "name": "Comment prévenir un infarctus cérébral postérieur ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une pression artérielle saine, une alimentation équilibrée et faire de l'exercice." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque d'AVC ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente significativement le risque d'accidents vasculaires cérébraux." } }, { "@type": "Question", "name": "L'activité physique peut-elle réduire le risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier aide à maintenir un cœur et des vaisseaux sanguins en bonne santé." } }, { "@type": "Question", "name": "Quels aliments sont à privilégier pour la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les fruits, légumes, grains entiers et poissons gras sont recommandés." } }, { "@type": "Question", "name": "Le contrôle du diabète est-il important ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon contrôle du diabète réduit le risque d'AVC et d'autres complications." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour un infarctus postérieur ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des anticoagulants, des thrombolytiques et la rééducation." } }, { "@type": "Question", "name": "Quelle est l'importance de la rééducation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La rééducation aide à récupérer les fonctions perdues et à améliorer la qualité de vie." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils prévenir d'autres AVC ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments comme l'aspirine peuvent réduire le risque d'AVC récurrents." } }, { "@type": "Question", "name": "Quand est-il nécessaire d'intervenir chirurgicalement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une intervention chirurgicale peut être nécessaire en cas d'hémorragie ou de pression intracrânienne." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des saignements, des réactions allergiques ou des douleurs." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après un AVC ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles de la parole, des problèmes de mobilité et des infections." } }, { "@type": "Question", "name": "Comment les troubles cognitifs peuvent-ils évoluer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent s'aggraver avec le temps, affectant la mémoire et la capacité de raisonnement." } }, { "@type": "Question", "name": "Les AVC peuvent-ils entraîner des problèmes émotionnels ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de l'humeur comme la dépression peuvent survenir après un AVC." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de nouveaux AVC ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant eu un AVC sont à risque accru de récidive." } }, { "@type": "Question", "name": "Comment gérer les complications à long terme ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une rééducation continue et un suivi médical régulier sont essentiels." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'AVC ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'infarctus cérébral ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'AVC augmente avec l'âge, surtout après 55 ans." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'AVC augmentent le risque personnel." } }, { "@type": "Question", "name": "Le stress peut-il contribuer au risque d'AVC ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la santé cardiovasculaire et augmenter le risque." } }, { "@type": "Question", "name": "Les maladies cardiaques sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies cardiaques comme la fibrillation auriculaire augmentent le risque d'AVC." } } ] } ] }

Sources (10000 au total)

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed and treated psychiatric disorders in childhood. Typically, children and adolescents with ADHD find it difficult to... To assess the beneficial and harmful effects of methylphenidate for children and adolescents with ADHD.... We searched CENTRAL, MEDLINE, Embase, three other databases and two trials registers up to March 2022. In addition, we checked reference lists and requested published and unpublished data from manufac... We included all randomised clinical trials (RCTs) comparing methylphenidate versus placebo or no intervention in children and adolescents aged 18 years and younger with a diagnosis of ADHD. The search... Two review authors independently conducted data extraction and risk of bias assessment for each trial. Six review authors including two review authors from the original publication participated in the... We included 212 trials (16,302 participants randomised); 55 parallel-group trials (8104 participants randomised), and 156 cross-over trials (8033 participants randomised) as well as one trial with a p... methylphenidate versus placebo or no intervention may improve teacher-rated ADHD symptoms (standardised mean difference (SMD) -0.74, 95% confidence interval (CI) -0.88 to -0.61; I² = 38%; 21 trials; 1... methylphenidate may cause more adverse events considered non-serious versus placebo or no intervention (RR 1.23, 95% CI 1.11 to 1.37; I² = 72%; 35 trials 5342 participants; very low-certainty evidence... The majority of our conclusions from the 2015 version of this review still apply. Our updated meta-analyses suggest that methylphenidate versus placebo or no-intervention may improve teacher-rated ADH...

Altered somatosensory processing in adult attention deficit hyperactivity disorder.

Tactile sensitivity and sensory overload in ADHD are well-documented in clinical-, self-, and parent- reports, but empirical evidence is scarce and ambiguous and focuses primarily on children. Here, w... Somatosensory evoked potential (SEP) amplitudes were measured in 27 adults with ADHD and 24 controls during four conditions (rest, stroking of the own arm, stroking of the arm by a researcher, and str... Participants with ADHD self-reported greater tactile sensitivity and ADHD symptom severity than controls and received higher scores on the Qb-test. These values correlated with one another. ADHD parti... We find that ADHD symptomatology and touch sensitivity are directly linked, using both self-reports and experimental measures. We also find evidence of tactile sensory overload in ADHD, and an indicat...

Sensory Processing in Children and Adolescents with Attention Deficit Hyperactivity Disorder.

The aim is to assess the sensory processing difficulties in children and adolescents with ADHD.... In all, 38 ADHD children of the age group 6-14 years and 34 age- and gender-matched typically developing controls were included in the study. Sensory processing was assessed on Child Sensory Profile-2... A significantly higher sensory processing difficulties were seen in children with ADHD than typically developing controls. There were positive correlations between the scores of Child sensory profile ... Sensory problems were common in children with ADHD and add to the functional impairments....

Preterm postnatal complications and risk of attention-deficit/hyperactivity disorder.

To investigate the association between the risk of attention-deficit/hyperactivity disorder (ADHD) and preterm birth and determine how postnatal complications in children born preterm is associated wi... This population-based cohort study used data from the Hong Kong electronic medical records. We followed 359 614 children (48% female; 6-17 years old, mean 11 years 7 months, SD 3 years 2 months) born ... The risk of ADHD was 4.0% in children born at term and 5.1% in children born preterm. The odds ratio for ADHD was 2.08 (95% confidence interval [CI] 1.64-2.64) for children born extremely preterm, 1.6... Children born preterm in all subcategories, from extremely preterm to late preterm, have increased risk of ADHD. Early respiratory infection partially mediates the risk of ADHD in children born preter...

Effect of Past Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder on Substance Use Disorder.

Substance use disorders (SUDs) are a considerable public health problem. Attention-deficit/hyperactivity disorder (ADHD) frequently occurs in patients with SUD. Several studies demonstrated that ADHD ... The study aimed to explore the effect of childhood ADHD pharmacotherapy on later life's functional impairment and substance use patterns.... Treatment-seeking SUD patients with ADHD (n = 52) were recruited from various rehabilitation facilities in South Africa. Adult ADHD individuals without SUD (n = 48) were recruited from clinicians, ret... Medicated participants (n = 59) showed lower levels of ADHD-related impairment across all functional domains (p < 0.001), compared to non-medicated participants (n = 41). They also consumed less alcoh... Childhood ADHD pharmacotherapy might be associated with a decreased risk for substance use in adulthood and lower ADHD-related impairment. Despite study limitations, these findings underline the impor...